The Misago self-expanding rapid-exchange nitinol stent system for the treatment of femoropopliteal occlusive disease in a prospective multicenter observational trial

The Misago self-expanding rapid-exchange nitinol stent system for the treatment of femoropopliteal occlusive disease in a prospective multicenter observational trial - Misago Japan Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010971

Enrollment

500

Registered

2013-06-15

Start date

2013-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral artery disease(femoropopliteal artery)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.ischemic change due femoropopliteal artery occlusive disease 2.Rutherford classification category 2 to 5 3.Rest or stressed ankle brachial index<0.9

Exclusion criteria

Exclusion criteria: 1.no need for stent inplantation 2.life expectancy is two years or less

Design outcomes

Primary

Measure	Time frame
Primary patency of 12months after procedure	—

Secondary

Measure	Time frame
All cause mortality Myocardial infarction Stroke Freedom from revascularization Freedom from bypass surgery Freedom from major amputation Symptomatic improvement Inprovement of Ankle Brachial index Stent thrombosis rate Stent fracture rate Technical successful rate Procedure complications	—

Countries

Japan

Contacts

Public ContactKaori Shimogama

Japan Endovascular Treatment Conference Japan Endovascular Treatment Conference

misago.registry@j-et.jp092-834-2815

Outcome results